Ashley Woodcock Selected Research

fluticasone furoate

1/2020	Real-World Data and Randomised Controlled Trials: The Salford Lung Study.
1/2020	Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies.
1/2019	Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups.
1/2018	Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study.
11/2017	Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial.
1/2016	Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice.
12/2015	The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma.
9/2015	The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease.
1/2015	Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.
9/2014	Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashley Woodcock Research Topics

Disease

62	Asthma (Bronchial Asthma) 12/2022 - 02/2002
20	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2006
12	Cough 01/2016 - 01/2006
6	Inflammation (Inflammations) 01/2021 - 08/2006
5	Chronic Cough 01/2016 - 10/2012
5	Respiratory Sounds (Crackle) 02/2011 - 10/2003
4	Eczema 06/2008 - 10/2003
2	Rhinitis 01/2020 - 05/2005
2	Oral Candidiasis (Thrush) 11/2012 - 01/2012
2	Hypersensitivity (Allergy) 01/2010 - 01/2008
1	Symptom Flare Up 01/2022
1	COVID-19 10/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Pneumonia (Pneumonitis) 01/2016
1	Hepatitis B 06/2013
1	Skin Neoplasms (Skin Cancer) 12/2012
1	Tremor (Tremors) 09/2012
1	Lung Diseases (Lung Disease) 02/2010
1	Peanut Hypersensitivity (Peanut Allergy) 01/2010
1	Septic Shock (Toxic Shock Syndrome) 04/2007
1	Respiratory Tract Infections (Respiratory Tract Infection) 05/2006
1	Allergic Rhinitis 05/2005
1	Airway Obstruction (Choking) 10/2003
1	Cicatrix (Scar) 10/2002
1	Respiratory Hypersensitivity 09/2002
1	Herpesviridae Infections (Herpesvirus Infection) 04/2002

Drug/Important Bio-Agent (IBA)

27	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 09/2002
22	fluticasone furoate FDA Link 01/2020 - 10/2011
17	vilanterolIBA 01/2020 - 01/2012
15	AllergensIBA 01/2010 - 03/2002
10	Fluticasone (Cutivate)FDA LinkGeneric 03/2014 - 09/2002
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2009
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 08/2003
6	SteroidsIBA 01/2022 - 06/2003
6	Salmeterol Xinafoate (Serevent)FDA Link 06/2014 - 07/2005
5	Immunoglobulin E (IgE)IBA 01/2010 - 02/2002
4	Capsaicin (Zostrix)FDA Link 01/2016 - 05/2013
4	Methacholine Chloride (Methacholine)FDA Link 01/2016 - 09/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2015 - 05/2006
3	Antitussive Agents (Antitussives)FDA Link 07/2014 - 04/2006
3	Volatile Organic CompoundsIBA 08/2012 - 02/2010
3	Citric Acid (Citrate)FDA LinkGeneric 09/2010 - 04/2006
2	Greenhouse GasesIBA 12/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 01/2018 - 06/2013
2	SmokeIBA 01/2016 - 01/2006
2	Bronchodilator Agents (Bronchodilators)IBA 02/2015 - 12/2011
2	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2012 - 01/2012
2	Codeine (Codeine Phosphate)FDA LinkGeneric 01/2010 - 04/2006
1	Carbon DioxideIBA 12/2022
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Janus Kinase InhibitorsIBA 10/2021
1	nezulcitinibIBA 10/2021
1	Drinking WaterIBA 01/2020
1	PeriostinIBA 01/2018
1	CytokinesIBA 02/2016
1	Dinoprostone (PGE2)FDA Link 01/2016
1	Complement System Proteins (Complement)IBA 12/2015
1	Muscarinic AntagonistsIBA 02/2015
1	SB 705498IBA 07/2014
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 10/2013
1	Gabapentin (Neurontin)FDA LinkGeneric 02/2013
1	Stratospheric OzoneIBA 12/2012
1	Pepsin A (Pepsin)IBA 10/2012
1	Glucose (Dextrose)FDA LinkGeneric 09/2012
1	PotassiumIBA 09/2012
1	Toll-Like Receptor 2IBA 02/2011
1	tenaxIBA 02/2010
1	Complex MixturesIBA 02/2010
1	Interleukin-13IBA 01/2010
1	tralokinumabIBA 01/2010
1	hypoxanthine arabinoside (ara-H)IBA 01/2010
1	8- (bis(2- chlorophenyl)methyl)- 3- (2- pyrimidinyl)- 8- azabicyclo(3.2.1)octan- 3- olIBA 01/2010
1	GlucocorticoidsIBA 07/2009
1	LipopolysaccharidesIBA 07/2009
1	Filaggrin ProteinsIBA 06/2008
1	SolutionsIBA 06/2008
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2007
1	GW 274150IBA 11/2007
1	montelukast (Singulair)FDA Link 09/2007
1	Enterotoxins (Enterotoxin)IBA 04/2007
1	AntibodiesIBA 04/2007
1	EndotoxinsIBA 08/2006
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2006
1	nasIBA 03/2006
1	Immunoglobulin G (IgG)IBA 03/2006
1	Peptide Hydrolases (Proteases)FDA Link 05/2005
1	CreatinineIBA 10/2003
1	reslizumabIBA 06/2003
1	Interleukin-5 (Interleukin 5)IBA 06/2003
1	Biological ProductsIBA 06/2003
1	Tuberculin (PPD)IBA 10/2002
1	norflurane (R 134a)IBA 09/2002

Therapy/Procedure

20	Therapeutics 12/2022 - 08/2002
7	Dry Powder Inhalers 12/2022 - 01/2012
5	Nebulizers and Vaporizers (Inhaler) 12/2022 - 07/2007
3	Metered Dose Inhalers (Metered Dose Inhaler) 12/2022 - 09/2002
2	Secondary Prevention 02/2015 - 08/2006
2	Medical Day Care (Partial Hospitalization) 02/2011 - 09/2008
1	Ambulatory Care (Outpatient Care) 03/2014